G2GBIO지투지바이오
456160 · KOSDAQ · ₩456160 · 지투지바이오
₩39,150▼ ₩6,050 (13.38%)End-of-day · Oct 27, 2026 · End-of-day prices.
Filings
- Investor relations (IR) event기업설명회(IR)개최Oct 26, 2026Open on DART
Predicted impact: Low
- Major management matter relevant to investors투자판단관련주요경영사항 (약효지속성 주사제 개발관련 플랫폼평가 계약 체결)Oct 19, 2026Open on DART
Predicted impact: Medium
Platform evaluation contract for long-acting injectables; terms undisclosed, firm has tiny revenue versus large market value.
- Adjustment of Conversion Price (6th Series)전환가액의조정 (제6회차)Sep 23, 2026Open on DART
- Adjustment of Conversion Price for Convertible Shares (Convertible Preferred Shares)전환주식의전환가액조정 (전환우선주)Sep 14, 2026Open on DART
- Adjustment of Conversion Price (5th Series)전환가액의조정 (제5회차)Sep 14, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험결과)Aug 27, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Aug 21, 2026Open on DART
- Half-year report (Jun 2026)반기보고서 (2026.06)Aug 14, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 5, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최Jul 1, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jun 5, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Jun 5, 2026Open on DART
- Amended: 5%+ holding report[기재정정]주식등의대량보유상황보고서(일반)Jun 5, 2026Open on DART
- Amended: 5%+ holding report[기재정정]주식등의대량보유상황보고서(일반)Jun 5, 2026Open on DART
- Amended: 5%+ holding report[기재정정]주식등의대량보유상황보고서(일반)Jun 5, 2026Open on DART
- Amended: Insider shareholding report[기재정정]임원ㆍ주요주주특정증권등소유상황보고서May 22, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서May 21, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서May 21, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서May 21, 2026Open on DART
- Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최Apr 14, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최Apr 14, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 27, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 27, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 27, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 27, 2026Open on DART
- Annual general meeting results정기주주총회결과Mar 26, 2026Open on DART
- Notice on Grant of Stock Purchase Options주식매수선택권부여에관한신고Mar 26, 2026Open on DART
- Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Mar 26, 2026Open on DART
- Results of Securities Issuance (Voluntary Disclosure) (6th Convertible Bond Issue)증권발행결과(자율공시) (제6회차 CB))Mar 23, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Mar 19, 2026Open on DART
- Audit report submitted감사보고서제출Mar 18, 2026Open on DART
- Annual report (Dec 2025)사업보고서 (2025.12)Mar 18, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최Mar 17, 2026Open on DART
- Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항 (장기지속형 미세구체 약물전달 기술 플랫폼 공동연구 및 기술이전계약 체결)Mar 16, 2026Open on DART
- Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항 (장기지속형 미세구체 약물전달 기술 플랫폼 공동연구 및 기술이전계약 체결)Mar 16, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항 (장기지속형 미세구체 약물전달 기술 플랫폼 공동연구 및 기술이전계약 체결)Mar 16, 2026Open on DART
- Convertible bond issue decision주요사항보고서(전환사채권발행결정)Mar 16, 2026Open on DART
- Results of Securities Issuance (Voluntary Disclosure) (5th Series CB)증권발행결과(자율공시) (제5회차 CB)Mar 12, 2026Open on DART
- Results of Securities Issuance (Voluntary Disclosure) (Third-Party Allotment – Convertible Preferred Shares)증권발행결과(자율공시) (제3자배정-전환우선주)Mar 12, 2026Open on DART
- Shareholders' meeting called주주총회소집결의Mar 11, 2026Open on DART
- Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Mar 11, 2026Open on DART
- Notice of shareholders' meeting주주총회소집공고Mar 11, 2026Open on DART
- Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)Mar 5, 2026Open on DART
- Amended: Convertible bond issue decision[기재정정]주요사항보고서(전환사채권발행결정)Mar 5, 2026Open on DART
- Convertible bond issue decision주요사항보고서(전환사채권발행결정)Feb 23, 2026Open on DART
- Rights offering (paid-in capital increase) decision주요사항보고서(유상증자결정)Feb 23, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Feb 13, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Feb 13, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Feb 13, 2026Open on DART
Titles in Korean until English translations are added.
Also known as: G2GBIO / 지투지바이오 / 456160 / KRX:456160
Source: KRX statistical information